Middle East Pharmaceutical Industries Co (SAU:4016) FCF Margin %: -4.00% (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SAU:4016 Middle East Pharmaceutical Industries Co SAU:4016
22 GF Score
Price ﷼60.55
! 3 Warning Signs
View Full Analysis

What is Middle East Pharmaceutical Industries Co FCF Margin %?

Middle East Pharmaceutical Industries Co SAU:4016 +0.92% 22 FCF Margin % is -4.00% as of Mar. 2026. GuruFocus rates SAU:4016 with a GF Score™ of 22/100. The stock has 3 warning signs investors should review. Among 960 Drug Manufacturers companies, Middle East Pharmaceutical Industries Co ranks better than 61.87% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Middle East Pharmaceutical Industries Co's Free Cash Flow for the three months ended in Mar. 2026 was ﷼-5.2 Mil. Middle East Pharmaceutical Industries Co's Revenue for the three months ended in Mar. 2026 was ﷼130.1 Mil. Therefore, Middle East Pharmaceutical Industries Co's FCF Margin % for the quarter that ended in Mar. 2026 was -4.00%.

As of today, Middle East Pharmaceutical Industries Co's current FCF Yield % is 1.59%.

The historical rank and industry rank for Middle East Pharmaceutical Industries Co's FCF Margin % or its related term are showing as below:

SAU:4016' s FCF Margin % Range Over the Past 10 Years
Min: 3.08   Med: 11.75   Max: 18.23
Current: 6.8


During the past 3 years, the highest FCF Margin % of Middle East Pharmaceutical Industries Co was 18.23%. The lowest was 3.08%. And the median was 11.75%.

SAU:4016's FCF Margin % is ranked better than
61.87% of 960 companies
in the Drug Manufacturers industry
Industry Median: 2.585 vs SAU:4016: 6.80


Middle East Pharmaceutical Industries Co FCF Margin % Related Terms


Middle East Pharmaceutical Industries Co FCF Margin % Historical Data

* Premium members only.

The historical data trend for Middle East Pharmaceutical Industries Co's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Middle East Pharmaceutical Industries Co FCF Margin % Chart

Middle East Pharmaceutical Industries Co Annual Data
Trend Dec23 Dec24 Dec25
FCF Margin %
18.23 3.08 11.75

Middle East Pharmaceutical Industries Co Quarterly Data
Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 15.78 15.08 15.16 3.37 -4.00

SAU:4016 vs ZTS, UTHR, VTRS: FCF Margin % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Middle East Pharmaceutical Industries Co's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Middle East Pharmaceutical Industries Co FCF Margin % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Middle East Pharmaceutical Industries Co's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Middle East Pharmaceutical Industries Co's FCF Margin % falls into.


SAU:4016
22GF Score
Middle East Pharmaceutical Industries Co SAU:4016
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Middle East Pharmaceutical Industries Co FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Middle East Pharmaceutical Industries Co's FCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=54.121/460.485
=11.75 %

Middle East Pharmaceutical Industries Co's FCF Margin for the quarter that ended in Mar. 2026 is calculated as

FCF Margin=Free Cash Flow (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-5.201/130.127
=-4.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of -4.00% mean?
Middle East Pharmaceutical Industries Co (SAU:4016) has a FCF Margin % of -4.00% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Middle East Pharmaceutical Industries Co and its competitors. Over the past decade, Middle East Pharmaceutical Industries Co's FCF Margin % has ranged from 3.08 to 18.23. According to the industry distribution chart, Middle East Pharmaceutical Industries Co ranks #366 out of 960 companies in the Drug Manufacturers industry, placing it in the top 38.1%.
Is Middle East Pharmaceutical Industries Co's FCF Margin % too high?
Middle East Pharmaceutical Industries Co's current FCF Margin % is -4.00%. Over the past 10 years, this metric has ranged from a low of 3.08 to a high of 18.23. Based on the distribution chart, Middle East Pharmaceutical Industries Co ranks #366 out of 960 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Middle East Pharmaceutical Industries Co has a GF Score™ of 22/100, reflecting its overall financial health beyond just this single metric.
How does Middle East Pharmaceutical Industries Co's FCF Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Middle East Pharmaceutical Industries Co ranks #366 out of 960 companies for FCF Margin %. This puts Middle East Pharmaceutical Industries Co in the upper half of its industry. The industry median FCF Margin % is 2.59. Historically, Middle East Pharmaceutical Industries Co's own FCF Margin % has ranged from 3.08 to 18.23 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Drug Manufacturers company?
The median FCF Margin % among Drug Manufacturers companies is 2.59, based on 960 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Middle East Pharmaceutical Industries Co and its competitors. For the Drug Manufacturers industry, the median FCF Margin % is 2.59 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Middle East Pharmaceutical Industries Co's current FCF Margin % is -4.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Middle East Pharmaceutical Industries Co stock overvalued right now?
Middle East Pharmaceutical Industries Co (SAU:4016) has a current FCF Margin % of -4.00%. The current FCF Margin % is -4.00%. Middle East Pharmaceutical Industries Co's overall GF Score™ is 22/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Middle East Pharmaceutical Industries Co (SAU:4016), the current FCF Margin % is -4.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Middle East Pharmaceutical Industries Co Business Description

Address 8146 King Muhammad V, Sulaimaniyah, P.O. Box 4180, Riyadh, SAU, 11491
Middle East Pharmaceutical Industries Co is a holding company engaged in manufacturing medicines, medicated and non-medicated creams and gels. The company operates in Private, Public, and Export segments. Geographically, it generates the majority of its revenue from Saudi Arabia.
22GF Score

Get the complete analysis for SAU:4016

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

﷼60.55
Price